Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: TPL BK Pacers.. Here it is Laurie

This sounds like the end of our run. I would expect the stock to tank after this little blurb. Doesn't this concern anyone?

-MIG expects to generate $200 million in licensing and litigation revenue over the

next five years, with nearly two thirds of the total revenue being returned to PDS for

distribution as royalties. This is achievable because MIG will create a small group of

licensing, business and engineering professionals to lead the effort for MMP.

Share
New Message
Please login to post a reply